An Advancing Sphere
Express Pharma|Express Pharma (Vol.13, No.13) May 1-15, 2018

Rising levels of COPD, including asthma are driving a lot of innovations in inhalers with an aim to improve the overall effective management of these diseases

Swati Rana
An Advancing Sphere
Chronic Obstructive Pulmonary Disease (COPD) was the fifth leading cause of death in 2002 and will become the third leading cause of death across the globe by 2030, according to WHO. Moreover, its incidence is expected to increase in the coming years due to higher smoking prevalence and ageing populations in many countries. The increase in COPD is one of the major growth drivers of pulmonary drug delivery market. According to markets and markets report, global pulmonary drug delivery market is projected to reach $52.37 billion by 2021 from $36.10 billion in 2016, at a CAGR of 6.5 percent during the forecast period. The report stated that the growth in this market is mainly driven by rising incidences of respiratory diseases such as COPD, asthma, and cystic fibrosis, increasing preference of pulmonary route of drug delivery and increasing technological developments in the form of smart/digital inhalers.

Although medication and treatment for COPD and asthma are available in oral, injectable dosage forms as well, inhaled therapy is preferred globally, because of the high drug concentration which can be achieved locally within the lungs, with reduced risk of systemic side effects. Global clinical guidelines issued by the Global Initiative for Asthma (GINA) and the Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommend that persistent, moderate-to-severe asthma and COPD at high risk of exacerbations be treated with a combination therapy of inhaled corticosteroid (ICS) and long-acting beta-agonist (LABA), administered via an inhaler. The guidelines also recognise that this therapy is best administered in a fixed-dose combination (FDC) from a single inhaler, rather than from two separate inhalers. This is demonstrated by reduced adherence and increased discontinuation rates in patients using multiple inhalers versus those using FDC devices. Thus, inhalers remain a major part of asthma treatment.

Trends in inhalers

Esta historia es de la edición Express Pharma (Vol.13, No.13) May 1-15, 2018 de Express Pharma.

Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.

Esta historia es de la edición Express Pharma (Vol.13, No.13) May 1-15, 2018 de Express Pharma.

Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.

MÁS HISTORIAS DE EXPRESS PHARMAVer todo
Blissfill-Calibrated syringe pipettes for repetitive laboratory dosing as per ISO 8655-9
Express Pharma

Blissfill-Calibrated syringe pipettes for repetitive laboratory dosing as per ISO 8655-9

Blissfill syringe pipettes provide laboratories with an ergonomic, self-refilling solution for repetitive dosing, delivering precise volumes from 0.05ml to 10ml. With ISO 8655-9 compliance and an included calibration certificate, Blissfill ensures accuracy and ease of use for high-demand lab applications

time-read
3 minutos  |
December 2024
Ensuring pharma compliance with testo data measurement technology
Express Pharma

Ensuring pharma compliance with testo data measurement technology

Comprehensive data measurement tools address regulatory demands and secure quality in pharma

time-read
4 minutos  |
December 2024
Waters launches software for lab-centric business intelligence enabling audit readiness
Express Pharma

Waters launches software for lab-centric business intelligence enabling audit readiness

waters_connect Data Intelligence software provides laboratories with comprehensive business intelligence on their chromatographic data throughout the product development lifecycle, enabling real-time audit readiness and query response, while reducing time spent on audit preparation

time-read
2 minutos  |
December 2024
Ensuring clean room integrity with Prime Clean Reset High-Speed Doors
Express Pharma

Ensuring clean room integrity with Prime Clean Reset High-Speed Doors

Designed with precision to meet the stringent requirements of controlled environments, Prime Clean Reset is the epitome of performance and reliability, ensuring that your clean room operations consistently meet the highest standards of regulatory compliance and product integrity

time-read
3 minutos  |
December 2024
Optimising efficiency with Remote Laboratory Solutions
Express Pharma

Optimising efficiency with Remote Laboratory Solutions

LabWare's comprehensive suite of software solutions designed specifically for laboratories offers reliable Remote Laboratory Solutions to help your business thrive in the current climate

time-read
1 min  |
December 2024
Ensuring water quality with the 6000TOCi: The ultimate solution for continuous TOC measurement
Express Pharma

Ensuring water quality with the 6000TOCi: The ultimate solution for continuous TOC measurement

The 6000TOCi Sensor is a comprehensive solution that brings together continuous monitoring, rapid response, reliability, and compliance

time-read
2 minutos  |
December 2024
Enhancing pharmaceutical analysis in critical areas
Express Pharma

Enhancing pharmaceutical analysis in critical areas

Dheeraj Handique, Manager GC/GCMS Product Marketing, Shimadzu Analytical (India) highlights the benefits of GCMS-TQ8050 NX with HS-20 NX trap for genotoxic impurities, nitrosamines, and, extractables and leachables

time-read
2 minutos  |
December 2024
Technical innovations for Annex 1
Express Pharma

Technical innovations for Annex 1

To meet the stringent EU GMP Annex 1 requirements, Optima presents innovative solutions to improve product and patient safety in pharmaceutical manufacturing. From minimising glove interventions and optimising First Air flow to advanced automation for integrity testing, this article explores how Optima's technologies support compliance in aseptic fill-and-finish processes

time-read
7 minutos  |
December 2024
JRS Pharma - The Global MCC Manufacturing Network
Express Pharma

JRS Pharma - The Global MCC Manufacturing Network

JRS Pharma is one of the largest manufacturers of MCC across the globe. The know-how is based on more than 25 years of experience in development of own processes

time-read
3 minutos  |
December 2024
Mack Pharmatech is the first to launch PLC-based environmental chambers in India
Express Pharma

Mack Pharmatech is the first to launch PLC-based environmental chambers in India

Manoj Choudhari, Managing Director, Mack Pharmatech shares insights on his company's pioneering expand globally and enhance regulatory compliance

time-read
3 minutos  |
December 2024